Merck discontinues Vibostolimab, Pembrolizumab coformulation arm of Phase 3 KeyVibe-010 trial in Melanoma Ruchika Sharma14 May 2024 4:17 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the discontinuation of the vibostolimab and pembrolizumab...
Study explores potential of oral melatonin in treating stubborn melasma Medha Baranwal14 May 2024 10:15 AM ISTIndia: Melasma, a common skin condition characterized by hyperpigmentation, has long been a challenge to treat effectively. However, a recent study...
Zydus Lifesciences Dexamethasone Tablets bags USFDA okay Ruchika Sharma13 May 2024 11:22 AM ISTAhmedabad: Zydus Lifesciences Limited has announced that the Company has received final approval from the United States Food and Drug...
Higher number of biologics required for control of coexisting PsA and atopic dermatitis: Study Jacinthlyn Sylvia13 May 2024 6:45 AM ISTA recent study published in the Journal of Personalized Medicine observed new insights regarding the treatment of psoriatic arthritis (PsA) and its...
Ruxolitinib Cream Shows Promise in Treating Adolescent Atopic Dermatitis: Study Medha Baranwal10 May 2024 9:30 PM ISTUSA: In a groundbreaking development in dermatology, the efficacy, safety, and long-term disease control of Ruxolitinib Cream among adolescents with...
Both targeted and whole-body NB-UVB are effective treatment options for acral vitiligo patients: Study Medha Baranwal9 May 2024 8:30 PM ISTIndia: In a groundbreaking development in acral vitiligo treatment, a split-body randomized controlled trial has demonstrated the efficacy of...
Zydus Lifesciences bags USFDA nod for Dapsone Gel for acne treatment Ruchika Sharma9 May 2024 2:52 PM ISTAhmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to market Dapsone...
USFDA approves Alembic Pharma five products in over a month Ruchika Sharma9 May 2024 1:05 PM ISTMumbai: Alembic Pharmaceuticals Limited announced today that it has received US Food & Drug Administration (USFDA) approvals on five of its...
No benefit of adjuvant leukotriene receptor antagonists with antihistamines in chronic urticaria: Study Medha Baranwal8 May 2024 8:00 PM ISTBrazil: A comprehensive systematic review and meta-analysis have shed new light on the potential of leukotriene receptor antagonists (LTAs) as...
Botulinum Toxin A emerges as promising treatment for female pattern hair loss: Study Medha Baranwal7 May 2024 10:30 PM ISTChina: In a breakthrough discovery in dermatology, a recent study has illuminated the potential of botulinum toxin A as a novel therapeutic option for...
Antioxidant-Rich Diets Linked to Improved Quality of Life for Young Women Battling Acne Vulgaris, Study Finds Medha Baranwal7 May 2024 8:30 AM ISTPoland: Acne vulgaris, a common skin condition affecting millions worldwide, often affects physical appearance and mental well-being. In a promising...
Tazarotene and Imiquimod Offer Similar Efficacy in Treating Plane Warts, reports study Dr Riya Dave6 May 2024 8:00 AM ISTResearchers have found that tazarotene 0.1% gel and imiquimod 5% cream offer similar efficacy in treating plane warts, according to a three-arm...
